painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain

ABSTRACT Objective: Nociceptive and neuropathic components both contribute to pain. Since these components require different pain management strategies, correct pain diagnosis before and during treatment is highly desirable. As low back pain (LBP) patients constitute an important subgroup of chronic pain patients, we addressed the following issues: (i) to establish a simple, validated screening tool to detect neuropathic pain (NeP) components in chronic LBP patients, (ii) to determine the prevalence of neuropathic pain components in LBP in a large-scale survey, and (iii) to determine whether LBP patients with an NeP component suffer from worse, or different, co-morbidities. Methods: In co-operation with the German Research Network on Neuropathic Pain we developed and validated the painDETECT questionnaire (PD‐Q) in a prospective, multicentre study and subsequently applied it to approximately 8000 LBP patients. Results: The PD‐Q is a reliable screening tool with high sensitivity, specificity and positive predictive accuracy; these were 84% in a palm-top computerised version and 85%, 80% and 83%, respectively, in a corresponding pencil-and-paper questionnaire. In an unselected cohort of chronic LBP patients, 37% were found to have predominantly neuropathic pain. Patients with NeP showed higher ratings of pain intensity, with more (and more severe) co‐morbidities such as depression, panic/anxiety and sleep disorders. This also affected functionality and use of health-care resources. On the basis of given prevalence of LBP in the general population, we calculated that 14.5% of all female and 11.4% of all male Germans suffer from LBP with a predominant neuropathic pain component. Conclusion: Simple, patient-based, easy-to-use screening questionnaires can determine the prevalence of neuropathic pain components both in individual LBP patients and in heterogeneous cohorts of such patients. Since NeP correlates with more intense pain, more severe co‐morbidity and poorer quality of life, accurate diagnosis is a milestone in choosing appropriate therapy.

[1]  S. Marcus,et al.  Evidence-based practice for acute low back pain in primary care: Patient outcomes and cost of care , 2006, Pain.

[2]  B. Collett,et al.  Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment , 2006, European journal of pain.

[3]  H. Ursin,et al.  Chapter 4 European guidelines for the management of chronic nonspecific low back pain , 2006, European Spine Journal.

[4]  T. Jensen,et al.  Mechanisms of Disease: mechanism-based classification of neuropathic pain—a critical analysis , 2006, Nature Clinical Practice Neurology.

[5]  Ralf Baron,et al.  Mechanisms of Disease: neuropathic pain—a clinical perspective , 2006, Nature Clinical Practice Neurology.

[6]  P. O'Sullivan.  Diagnosis and classification of chronic low back pain disorders: maladaptive movement and motor control impairments as underlying mechanism. , 2005, Manual therapy.

[7]  H. Neuhauser,et al.  Chronische Rückenschmerzen in der Allgemeinbevölkerung in Deutschland 2002/2003: Prävalenz und besonders betroffene Bevölkerungsgruppen , 2005 .

[8]  Bernard Laurent,et al.  Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) , 2005, Pain.

[9]  S. Paul,et al.  Categorizing the severity of cancer pain: further exploration of the establishment of cutpoints , 2005, Pain.

[10]  J. Unützer,et al.  Monitoring Depression Treatment Outcomes With the Patient Health Questionnaire-9 , 2004, Medical care.

[11]  C. Bombardier,et al.  Quality of Primary Care Guidelines for Acute Low Back Pain , 2004, Spine.

[12]  T. Jensen,et al.  Symptoms and signs in patients with suspected neuropathic pain , 2004, Pain.

[13]  R. Baron,et al.  [How neuropathic is sciatica? The mixed pain concept]. , 2004, Der Orthopade.

[14]  G. Cruccu,et al.  EFNS guidelines on neuropathic pain assessment , 2004, European journal of neurology.

[15]  Mario Saltarelli,et al.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. , 2003, Archives of neurology.

[16]  Mark P. Jensen,et al.  Questionnaire Validation: A Brief Guide for Readers of the Research Literature , 2003, The Clinical journal of pain.

[17]  Misha-Miroslav Backonja,et al.  Development of a Neuropathic Pain Questionnaire , 2003, The Clinical journal of pain.

[18]  James Neil Weinstein,et al.  Low back pain [5] (multiple letters) , 2001 .

[19]  M. Bennett,et al.  The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs , 2001, Pain.

[20]  E. Skovlund,et al.  A comparison of pain rating scales by sampling from clinical trial data. , 2000, The Clinical journal of pain.

[21]  T. Kohlmann,et al.  [Hannover Functional Questionnaire in ambulatory diagnosis of functional disability caused by backache]. , 1996, Die Rehabilitation.

[22]  H. Neuhauser,et al.  [Chronic back pain in the general population in Germany 2002/2003: prevalence and highly affected population groups]. , 2005, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).

[23]  R. Hays,et al.  Psychometric properties of the Medical Outcomes Study Sleep measure. , 2005, Sleep medicine.

[24]  N. B. Finnerupa,et al.  Algorithm for neuropathic pain treatment: An evidence based proposal , 2005 .